APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canagliflozin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Canagliflozin Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchCanagliflozin Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Canagliflozin Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Canagliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canagliflozin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Canagliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Canagliflozin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Canagliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Canagliflozin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Canagliflozin market include Hansoh Pharma, Mitsubishi Tanabe Pharma, Hinye and Janssen Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Canagliflozin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Canagliflozin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Canagliflozin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Canagliflozin market size, projected growth trends, production technologies, key applications, and end-use industries.

Canagliflozin Segment by Company

Hansoh Pharma

Mitsubishi Tanabe Pharma

Hinye

Janssen Pharmaceuticals

Canagliflozin Segment by Type

100mg

300mg

Canagliflozin Segment by Application

Diabetes

Heart Disease

Others

Canagliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Canagliflozin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Canagliflozin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Canagliflozin significant trends, drivers, influence factors in global and regions.

6. To analyze Canagliflozin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canagliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canagliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canagliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Canagliflozin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Canagliflozin industry.

Chapter 3: Detailed analysis of Canagliflozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Canagliflozin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Canagliflozin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Canagliflozin Industry Trends Table 2. Canagliflozin Industry Drivers Table 3. Canagliflozin Industry Opportunities and Challenges Table 4. Canagliflozin Industry Restraints Table 5. Global Canagliflozin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Canagliflozin Revenue Share by Company (2021-2026) Table 7. Global Canagliflozin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Canagliflozin Sales Volume Share by Company (2021-2026) Table 9. Global Canagliflozin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Canagliflozin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Canagliflozin Key Company Manufacturing Base & Headquarters Table 12. Global Canagliflozin Company, Product Type & Application Table 13. Global Canagliflozin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Canagliflozin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg Table 18. Significant Companies of 300mg Table 19. Global Canagliflozin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Canagliflozin Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Canagliflozin Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Canagliflozin Sales Volume Share by Type (2021-2026) Table 23. Global Canagliflozin Sales Volume Share by Type (2027-2032) Table 24. Global Canagliflozin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Canagliflozin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Canagliflozin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Canagliflozin Sales Value Share by Type (2021-2026) Table 28. Global Canagliflozin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diabetes Table 30. Significant Companies of Heart Disease Table 31. Significant Companies of Others Table 32. Global Canagliflozin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Canagliflozin Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Canagliflozin Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Canagliflozin Sales Volume Share by Application (2021-2026) Table 36. Global Canagliflozin Sales Volume Share by Application (2027-2032) Table 37. Global Canagliflozin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Canagliflozin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Canagliflozin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Canagliflozin Sales Value Share by Application (2021-2026) Table 41. Global Canagliflozin Sales Value Share by Application (2027-2032) Table 42. Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Canagliflozin Sales by Region (2021-2026) & (K Units) Table 44. Global Canagliflozin Sales Market Share by Region (2021-2026) Table 45. Global Canagliflozin Sales by Region (2027-2032) & (K Units) Table 46. Global Canagliflozin Sales Market Share by Region (2027-2032) Table 47. Global Canagliflozin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Canagliflozin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Canagliflozin Sales Value Share by Region (2021-2026) Table 50. Global Canagliflozin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Canagliflozin Sales Value Share by Region (2027-2032) Table 52. Global Canagliflozin Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Canagliflozin Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Canagliflozin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Canagliflozin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Canagliflozin Sales by Country (2021-2026) & (K Units) Table 57. Global Canagliflozin Sales Market Share by Country (2021-2026) Table 58. Global Canagliflozin Sales by Country (2027-2032) & (K Units) Table 59. Global Canagliflozin Sales Market Share by Country (2027-2032) Table 60. Global Canagliflozin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Canagliflozin Sales Value Market Share by Country (2021-2026) Table 62. Global Canagliflozin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Canagliflozin Sales Value Market Share by Country (2027-2032) Table 64. Hansoh Pharma Company Information Table 65. Hansoh Pharma Business Overview Table 66. Hansoh Pharma Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Hansoh Pharma Canagliflozin Product Portfolio Table 68. Hansoh Pharma Recent Development Table 69. Mitsubishi Tanabe Pharma Company Information Table 70. Mitsubishi Tanabe Pharma Business Overview Table 71. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio Table 73. Mitsubishi Tanabe Pharma Recent Development Table 74. Hinye Company Information Table 75. Hinye Business Overview Table 76. Hinye Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hinye Canagliflozin Product Portfolio Table 78. Hinye Recent Development Table 79. Janssen Pharmaceuticals Company Information Table 80. Janssen Pharmaceuticals Business Overview Table 81. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Janssen Pharmaceuticals Canagliflozin Product Portfolio Table 83. Janssen Pharmaceuticals Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Canagliflozin Distributors List Table 87. Canagliflozin Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Canagliflozin Product Image Figure 2. Global Canagliflozin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Canagliflozin Sales (2021-2032) & (K Units) Figure 5. Global Canagliflozin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Canagliflozin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg Image Figure 10. 300mg Image Figure 11. Global Canagliflozin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Canagliflozin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Canagliflozin Sales Volume Share by Type (2021-2032) Figure 14. Global Canagliflozin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Canagliflozin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Canagliflozin Sales Value Share by Type (2021-2032) Figure 17. Diabetes Image Figure 18. Heart Disease Image Figure 19. Others Image Figure 20. Global Canagliflozin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Canagliflozin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Canagliflozin Sales Volume Share by Application (2021-2032) Figure 23. Global Canagliflozin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Canagliflozin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Canagliflozin Sales Value Share by Application (2021-2032) Figure 26. Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Canagliflozin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Canagliflozin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Canagliflozin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Canagliflozin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Canagliflozin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Canagliflozin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Canagliflozin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Canagliflozin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Canagliflozin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Canagliflozin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Canagliflozin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Canagliflozin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Canagliflozin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Canagliflozin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 300mg
Applications
  • Diabetes
  • Heart Disease
  • Others
Companies covered
  • Hansoh Pharma
  • Mitsubishi Tanabe Pharma
  • Hinye
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Canagliflozin Sales Value (2021-2032)
  4. 1.2.2 Global Canagliflozin Sales Volume (2021-2032)
  5. 1.2.3 Global Canagliflozin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Canagliflozin Market Dynamics
  1. 2.1 Canagliflozin Industry Trends
  2. 2.2 Canagliflozin Industry Drivers
  3. 2.3 Canagliflozin Industry Opportunities and Challenges
  4. 2.4 Canagliflozin Industry Restraints
3 Canagliflozin Market by Company
  1. 3.1 Global Canagliflozin Company Revenue Ranking in 2025
  2. 3.2 Global Canagliflozin Revenue by Company (2021-2026)
  3. 3.3 Global Canagliflozin Sales Volume by Company (2021-2026)
  4. 3.4 Global Canagliflozin Average Price by Company (2021-2026)
  5. 3.5 Global Canagliflozin Company Ranking (2024-2026)
  6. 3.6 Global Canagliflozin Company Manufacturing Base and Headquarters
  7. 3.7 Global Canagliflozin Company Product Type and Application
  8. 3.8 Global Canagliflozin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Canagliflozin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Canagliflozin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Canagliflozin Market by Type
  1. 4.1 Canagliflozin Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 300mg
  4. 4.2 Global Canagliflozin Sales Volume by Type
  5. 4.2.1 Global Canagliflozin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Canagliflozin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Canagliflozin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Canagliflozin Sales Value by Type
  9. 4.3.1 Global Canagliflozin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Canagliflozin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Canagliflozin Sales Value Share by Type (2021-2032)
5 Canagliflozin Market by Application
  1. 5.1 Canagliflozin Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Heart Disease
  4. 5.1.3 Others
  5. 5.2 Global Canagliflozin Sales Volume by Application
  6. 5.2.1 Global Canagliflozin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canagliflozin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Canagliflozin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Canagliflozin Sales Value by Application
  10. 5.3.1 Global Canagliflozin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Canagliflozin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Canagliflozin Sales Value Share by Application (2021-2032)
6 Canagliflozin Regional Sales and Value Analysis
  1. 6.1 Global Canagliflozin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Canagliflozin Sales by Region (2021-2032)
  3. 6.2.1 Global Canagliflozin Sales by Region: 2021-2026
  4. 6.2.2 Global Canagliflozin Sales by Region (2027-2032)
  5. 6.3 Global Canagliflozin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Canagliflozin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Canagliflozin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Canagliflozin Sales Value by Region (2027-2032)
  9. 6.5 Global Canagliflozin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Canagliflozin Sales Value (2021-2032)
  12. 6.6.2 North America Canagliflozin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Canagliflozin Sales Value (2021-2032)
  15. 6.7.2 Europe Canagliflozin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Canagliflozin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Canagliflozin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Canagliflozin Sales Value (2021-2032)
  21. 6.9.2 South America Canagliflozin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Canagliflozin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Canagliflozin Sales Value Share by Country, 2025 VS 2032
7 Canagliflozin Country-level Sales and Value Analysis
  1. 7.1 Global Canagliflozin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Canagliflozin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Canagliflozin Sales by Country (2021-2032)
  4. 7.3.1 Global Canagliflozin Sales by Country (2021-2026)
  5. 7.3.2 Global Canagliflozin Sales by Country (2027-2032)
  6. 7.4 Global Canagliflozin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Canagliflozin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Canagliflozin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Canagliflozin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Canagliflozin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Canagliflozin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Canagliflozin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Canagliflozin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Canagliflozin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Canagliflozin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Canagliflozin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Canagliflozin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Canagliflozin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Canagliflozin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Canagliflozin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Canagliflozin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Canagliflozin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Canagliflozin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Canagliflozin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Canagliflozin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Canagliflozin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Canagliflozin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Canagliflozin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Canagliflozin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Canagliflozin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Canagliflozin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Canagliflozin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Canagliflozin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Canagliflozin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Canagliflozin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Canagliflozin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Canagliflozin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Canagliflozin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Canagliflozin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Canagliflozin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Canagliflozin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Canagliflozin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Canagliflozin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Canagliflozin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Canagliflozin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Canagliflozin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Canagliflozin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Canagliflozin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Canagliflozin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Canagliflozin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Canagliflozin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Canagliflozin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Canagliflozin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Canagliflozin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Canagliflozin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Canagliflozin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Canagliflozin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Canagliflozin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Canagliflozin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Canagliflozin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Canagliflozin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Canagliflozin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Canagliflozin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Canagliflozin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Canagliflozin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Canagliflozin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Canagliflozin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Canagliflozin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Canagliflozin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Canagliflozin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Canagliflozin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Canagliflozin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Canagliflozin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Canagliflozin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Canagliflozin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Canagliflozin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Canagliflozin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Canagliflozin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Canagliflozin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Canagliflozin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Canagliflozin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Canagliflozin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Canagliflozin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Canagliflozin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Canagliflozin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Canagliflozin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Canagliflozin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Canagliflozin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Canagliflozin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Canagliflozin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Canagliflozin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Canagliflozin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hansoh Pharma
  2. 8.1.1 Hansoh Pharma Company Information
  3. 8.1.2 Hansoh Pharma Business Overview
  4. 8.1.3 Hansoh Pharma Canagliflozin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hansoh Pharma Canagliflozin Product Portfolio
  6. 8.1.5 Hansoh Pharma Recent Developments
  7. 8.2 Mitsubishi Tanabe Pharma
  8. 8.2.1 Mitsubishi Tanabe Pharma Company Information
  9. 8.2.2 Mitsubishi Tanabe Pharma Business Overview
  10. 8.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio
  12. 8.2.5 Mitsubishi Tanabe Pharma Recent Developments
  13. 8.3 Hinye
  14. 8.3.1 Hinye Company Information
  15. 8.3.2 Hinye Business Overview
  16. 8.3.3 Hinye Canagliflozin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hinye Canagliflozin Product Portfolio
  18. 8.3.5 Hinye Recent Developments
  19. 8.4 Janssen Pharmaceuticals
  20. 8.4.1 Janssen Pharmaceuticals Company Information
  21. 8.4.2 Janssen Pharmaceuticals Business Overview
  22. 8.4.3 Janssen Pharmaceuticals Canagliflozin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Janssen Pharmaceuticals Canagliflozin Product Portfolio
  24. 8.4.5 Janssen Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Canagliflozin Value Chain Analysis
  2. 9.1.1 Canagliflozin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Canagliflozin Sales Mode & Process
  6. 9.2 Canagliflozin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Canagliflozin Distributors
  9. 9.2.3 Canagliflozin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst